S Peller

926 total citations
41 papers, 780 citations indexed

About

S Peller is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, S Peller has authored 41 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in S Peller's work include Cancer-related Molecular Pathways (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Platelet Disorders and Treatments (4 papers). S Peller is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Platelet Disorders and Treatments (4 papers). S Peller collaborates with scholars based in Israel, Türkiye and Canada. S Peller's co-authors include Varda Rotter, S Kaufman, Miron Prokocimer, Y. Bistritz, Gideon Rechavi, Yair S. Manor, Zvi Kelman, Ariel Halevy, S Slutzki and R. Halperin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Oncogene.

In The Last Decade

S Peller

38 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Peller Israel 16 323 304 168 144 122 41 780
Arnold D. Rubin United States 17 132 0.4× 289 1.0× 115 0.7× 175 1.2× 245 2.0× 33 848
Dennis W. Ross United States 15 114 0.4× 191 0.6× 107 0.6× 84 0.6× 53 0.4× 43 604
Chika Iwamoto Japan 18 449 1.4× 357 1.2× 98 0.6× 66 0.5× 316 2.6× 41 1.0k
Lisa Haley United States 18 290 0.9× 526 1.7× 84 0.5× 78 0.5× 47 0.4× 39 1.1k
Elaine Sobral da Costa Brazil 19 207 0.6× 422 1.4× 386 2.3× 163 1.1× 192 1.6× 65 1.1k
Enrique Colado Spain 16 159 0.5× 241 0.8× 327 1.9× 99 0.7× 165 1.4× 35 683
Miyuki Suguro Japan 16 309 1.0× 245 0.8× 163 1.0× 130 0.9× 118 1.0× 34 878
Yin Tong China 15 203 0.6× 325 1.1× 145 0.9× 33 0.2× 96 0.8× 45 603
Jordan Goldstein United States 17 104 0.3× 117 0.4× 270 1.6× 67 0.5× 50 0.4× 58 914
Alec Morley Australia 18 337 1.0× 223 0.7× 439 2.6× 173 1.2× 364 3.0× 40 1.2k

Countries citing papers authored by S Peller

Since Specialization
Citations

This map shows the geographic impact of S Peller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Peller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Peller more than expected).

Fields of papers citing papers by S Peller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Peller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Peller. The network helps show where S Peller may publish in the future.

Co-authorship network of co-authors of S Peller

This figure shows the co-authorship network connecting the top 25 collaborators of S Peller. A scholar is included among the top collaborators of S Peller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Peller. S Peller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prokocimer, Miron & S Peller. (2011). Cytoplasmic sequestration of wild-type p53 in a patient with therapy-related resistant AML: first report. Medical Oncology. 29(2). 1148–1150. 4 indexed citations
2.
Peller, S, Tsvee Lapidot, Joy Kahn, et al.. (2003). The onset of p53-dependent apoptosis plays a role in terminal differentiation of human normoblasts. Oncogene. 22(30). 4648–4655. 21 indexed citations
3.
Peller, S. (2000). Walter Reed, C. Finlay, and their predecessors around 1800.. PubMed. 33(3). 195–211.
4.
Halperin, R., S Peller, Judith Sandbank, Ian Bukovsky, & David F. Schneider. (2000). Expression of the p53 Gene and Apoptosis in Gestational Trophoblastic Disease. Placenta. 21(1). 58–62. 32 indexed citations
5.
Peller, S, et al.. (1999). Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma.. Oncology Reports. 6(1). 193–7. 33 indexed citations
6.
Prokocimer, Miron, S Peller, Hannah Ben‐Bassat, Naomi Goldfinger, & Varda Rotter. (1998). P53 Gene Mutation in a T-Acute Lymphoblastic Leukemia Cell Line (Loucy) with t(16:20) and 5q-Chromosomal Aberrations. Leukemia & lymphoma. 29(5-6). 607–611. 4 indexed citations
7.
Peller, S. (1998). Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response. Seminars in Cancer Biology. 8(5). 379–387. 52 indexed citations
8.
Peller, S, et al.. (1995). p53 mutations in matched primary and metastatic human tumors. Molecular Carcinogenesis. 13(3). 166–172. 30 indexed citations
9.
Peller, S, et al.. (1995). A Novel Polymorphism in Intron 6 of the Human p53 Gene: A Possible Association with Cancer Predisposition and Susceptibility. DNA and Cell Biology. 14(12). 983–990. 47 indexed citations
10.
Peller, S, et al.. (1994). Immunological profile changes following perioperative autologous vs. homologous blood transfusion in oncologic patients. Journal of Surgical Oncology. 56(2). 98–101. 9 indexed citations
11.
Bistritz, Y. & S Peller. (1993). Immittance spectral pairs (ISP) for speech encoding. IEEE International Conference on Acoustics Speech and Signal Processing. 9–12 vol.2. 42 indexed citations
12.
Peleg, David, et al.. (1992). Inherited C3 deficiency and meningococcal disease in a teenager. The Pediatric Infectious Disease Journal. 11(5). 401–403. 16 indexed citations
13.
Peller, S & S Kaufman. (1991). Decreased CD45RA T cells in B-cell chronic lymphatic leukemia patients: correlation with disease stage. Blood. 78(6). 1569–1573. 3 indexed citations
14.
Kornberg, Abraham, et al.. (1990). Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines. Blood. 76(4). 814–819. 1 indexed citations
15.
Kohelet, David, S Peller, Eliana Arbel, & Michael Goldberg. (1990). Preincubation with Intravenous Lipid Emulsion Reduces Chemotactic Motility of Neutrophils in Cord Blood. Journal of Parenteral and Enteral Nutrition. 14(5). 472–473. 13 indexed citations
16.
Kornberg, Abraham, et al.. (1990). Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines. Blood. 76(4). 814–819. 8 indexed citations
17.
Segal, Raphael, Molly Dayan, Nava Epstein, et al.. (1989). Common variable immunodeficiency: A family study and therapeutic trial with cimetidine. Journal of Allergy and Clinical Immunology. 84(5). 753–761. 15 indexed citations
18.
Modai, David, et al.. (1989). Increased concanavalin A-induced suppressor cell activity in humans with occupational lead exposure. Environmental Research. 48(1). 1–6. 19 indexed citations
19.
Modai, David, Joshua Weissgarten, S Peller, et al.. (1988). Effect of Levamisole on Chemotaxis of Granulocytes from Uremic Patients. ˜The œNephron journals/Nephron journals. 49(3). 237–239. 6 indexed citations
20.
Peller, S, et al.. (1955). Leukemia in American physicians.. PubMed. 11(3). 292–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026